By Stacy Lipson
Posting in Technology
Sepsis drug Xigris pulled from the market after drug failed to show benefits.
According to a prepared statement, Timothy Garnett, chief medical official at Eli Lilly said:
"While there were no new safety findings, the study failed to demonstrate that Xigris improved patient survival and thus calls into question the benefit-risk profile of Xigris and its continued use," Timothy Garnett, Lilly's chief medical officer, said in a prepared statement. "Patients currently receiving treatment with Xigris should have treatment discontinued, and Xigris treatment should not be initiated for new patients."
In a prepared statement on the European Medicines Agency website, the site stated:
"These results call into question the overall benefit-risk balance of Xigris for the indicated patient population (severe sepsis). Eli Lilly has thus decided to withdraw the product from the market worldwide."
Image via Flickr user emagineart
To learn more about Xigris, visit the official website here.
Oct 27, 2011
I'm puzzled here. Does the drug manufacturer not have to demonstrate to the FDA the efficacy and safety of the medication as part of the approval process? Does the FDA not assess, verify, and approve these data? How then, did this medication gain entry into the marketplace as a safe and efficient product? Indeed, a disturbing situation.
Why not? The company gains revenue to pay for research, and the governments gain revenue via taxes.. the general population are spoon fed virtually anything by our Doctors, Governments and Media... at will.... Will they refund people/health insurance companies, governments, for selling them high price placebos?